Key facts
- NOVARTIS PHARMA AG filed SCHEDULE 13G/A for Erasca, Inc. Common stock, par value $0.0001 per share (ERAS).
- Disclosed ownership: 4.4%.
- Date of event: 31 Dec 2024.
NOVARTIS PHARMA AG - 31 Dec 2024 SCHEDULE 13G/A Report for Erasca, Inc. Common stock, par value $0.0001 per share (ERAS)
- Filing manager
- NOVARTIS PHARMA AG
- Reporting owner
- Novartis Pharma AG
- Symbol
- ERAS
- Shares outstanding
- 279,720,273 shares
- Disclosed shares
- 12,307,692 shares
- Ownership percentage
- 4.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 17:02:05 UTC
- Event date
- 31 Dec 2024
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
NOVARTIS PHARMA AG disclosed 4.4% ownership in Erasca, Inc. Common stock, par value $0.0001 per share (ERAS) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 17:02.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novartis Pharma AG | 4.4% | 12,307,692 | 0 | 12,307,692 | /s/ Christian Rehm | Christian Rehm | |
| Novartis AG | 4.4% | 12,307,692 | 0 | 12,307,692 | /s/ Christian Rehm | Christian Rehm |
CIK / CUSIP context first